Skip to main content
BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.40
-0.15 (-0.73%)
Nov 13, 2026, 1:30 PM CST

BioGend Therapeutics Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
235.24222.34167.65109.9131.459.27
Revenue Growth
10.74%32.62%52.53%249.51%239.26%565.40%
Gross Profit
170.37160.16130.5189.6222.783.06
Operating Income
-108.48-110.5-122.26-176.54-219.21-164.31
Net Income
-83.22-84.61-116.47-156.33-184.46-138.49
Earnings Per Share
-0.66-0.69-0.95-1.30-1.79-1.37
EPS Growth
------

Revenue by Geography
Chart
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan
218.69161.4173.5431.148.99
Japan
-0.724.880.01-
Hong Kong and Chinese Mainland
2.221.14---
Other
-2.50.10.3-
Malaysia
1.431.9---
Total
222.34167.65109.9131.459.27

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
824.4517.9619.02724.27493.4689.28
Total Debt
3.836.589.4313.0915.774.42
Net Cash (Debt)
820.56511.33609.59711.18477.64684.86
Net Cash Growth
56.43%-16.12%-14.28%48.90%-30.26%33.49%
Net Cash Per Share
6.474.154.955.914.636.76

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-59.34-63.66-98.91-138.72-168.78-136.8
Capital Expenditures
-3.09-1.87-0.65-26.04-18.18-0.67
Free Cash Flow
-62.43-65.52-99.56-164.76-186.96-137.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
72.42%72.03%77.85%81.54%72.44%33.00%
Operating Margin
-46.11%-49.70%-72.93%-160.63%-697.11%-1772.67%
Pretax Margin
-42.23%-46.60%-76.50%-153.97%-680.20%-1556.45%
Profit Margin
-35.38%-38.05%-69.47%-142.23%-586.58%-1494.07%
FCF Margin
-26.54%-29.47%-59.38%-149.91%-594.54%-1483.13%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.6521.4824.9442.8371.46297.47